Markets News Monday: Elan sells 75% of its Athlone operation for $960m to US biotech firm Alkermes
May 9th, 2011 | By Finfacts Ireland Business & Finance Portal | Category: News worldwide
Markets news on stocks, currencies and commodities; Elan sells 75% of its Athlone operation for $960m to US biotech firm Alkermes.